位置:首页 > 蛋白库 > DNM3L_HUMAN
DNM3L_HUMAN
ID   DNM3L_HUMAN             Reviewed;         386 AA.
AC   Q9UJW3; E9PB42; Q9BUJ4;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   03-AUG-2022, entry version 178.
DE   RecName: Full=DNA (cytosine-5)-methyltransferase 3-like;
GN   Name=DNMT3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10857753; DOI=10.1006/geno.2000.6168;
RA   Aapola U., Shibuya K., Scott H.S., Ollila J., Vihinen M., Heino M.,
RA   Shintani A., Kawasaki K., Minoshima S., Krohn K., Antonarakis S.E.,
RA   Shimizu N., Kudoh J., Peterson P.;
RT   "Isolation and initial characterization of a novel zinc finger gene,
RT   DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene
RT   family.";
RL   Genomics 65:293-298(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-278.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS), FUNCTION, AND HOMODIMERIZATION.
RX   PubMed=17687327; DOI=10.1038/nature05987;
RA   Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z.,
RA   Erdjument-Bromage H., Tempst P., Lin S.-P., Allis C.D., Cheng X.,
RA   Bestor T.H.;
RT   "DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation
RT   of DNA.";
RL   Nature 448:714-717(2007).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.89 ANGSTROMS) OF 160-387, SUBUNIT, AND MUTAGENESIS
RP   OF PHE-261.
RX   PubMed=17713477; DOI=10.1038/nature06146;
RA   Jia D., Jurkowska R.Z., Zhang X., Jeltsch A., Cheng X.;
RT   "Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA
RT   methylation.";
RL   Nature 449:248-251(2007).
CC   -!- FUNCTION: Catalytically inactive regulatory factor of DNA
CC       methyltransferases that can either promote or inhibit DNA methylation
CC       depending on the context (By similarity). Essential for the function of
CC       DNMT3A and DNMT3B: activates DNMT3A and DNMT3B by binding to their
CC       catalytic domain (PubMed:17687327). Acts by accelerating the binding of
CC       DNA and S-adenosyl-L-methionine (AdoMet) to the methyltransferases and
CC       dissociates from the complex after DNA binding to the
CC       methyltransferases (PubMed:17687327). Recognizes unmethylated histone
CC       H3 lysine 4 (H3K4me0) and induces de novo DNA methylation by
CC       recruitment or activation of DNMT3 (PubMed:17687327). Plays a key role
CC       in embryonic stem cells and germ cells (By similarity). In germ cells,
CC       required for the methylation of imprinted loci together with DNMT3A (By
CC       similarity). In male germ cells, specifically required to methylate
CC       retrotransposons, preventing their mobilization (By similarity). Plays
CC       a key role in embryonic stem cells (ESCs) by acting both as an positive
CC       and negative regulator of DNA methylation (By similarity). While it
CC       promotes DNA methylation of housekeeping genes together with DNMT3A and
CC       DNMT3B, it also acts as an inhibitor of DNA methylation at the promoter
CC       of bivalent genes (By similarity). Interacts with the EZH2 component of
CC       the PRC2/EED-EZH2 complex, preventing interaction of DNMT3A and DNMT3B
CC       with the PRC2/EED-EZH2 complex, leading to maintain low methylation
CC       levels at the promoters of bivalent genes (By similarity). Promotes
CC       differentiation of ESCs into primordial germ cells by inhibiting DNA
CC       methylation at the promoter of RHOX5, thereby activating its expression
CC       (By similarity). {ECO:0000250|UniProtKB:Q9CWR8,
CC       ECO:0000269|PubMed:17687327}.
CC   -!- SUBUNIT: Homodimer (PubMed:17687327, PubMed:17713477). Heterotetramer
CC       composed of 1 DNMT3A homodimer and 2 DNMT3L subunits (DNMT3L-DNMT3A-
CC       DNMT3A-DNMT3L) (PubMed:17713477). Interacts with histone H3 (via N-
CC       terminus); interaction is strongly inhibited by methylation at lysine 4
CC       (H3K4me) (PubMed:17687327). Interacts with EZH2; the interaction is
CC       direct (By similarity). Interacts with SPOCD1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9CWR8, ECO:0000269|PubMed:17687327,
CC       ECO:0000269|PubMed:17713477}.
CC   -!- INTERACTION:
CC       Q9UJW3; Q13547: HDAC1; NbExp=3; IntAct=EBI-740967, EBI-301834;
CC       Q9UJW3; Q17RL8: PDZD4; NbExp=3; IntAct=EBI-740967, EBI-10239064;
CC       Q9UJW3; Q9UHA3: RSL24D1; NbExp=7; IntAct=EBI-740967, EBI-749321;
CC       Q9UJW3-1; Q9Y6K1: DNMT3A; NbExp=5; IntAct=EBI-15650345, EBI-923653;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Other splice isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9UJW3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJW3-2; Sequence=VSP_041295;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in several tissues
CC       including testis, ovary, and thymus. {ECO:0000269|PubMed:10857753}.
CC   -!- MISCELLANEOUS: Interaction with histone H3 is strongly inhibited by
CC       methylation at lysine 4 (H3K4me).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF194032; AAF05812.1; -; mRNA.
DR   EMBL; AP001753; BAA95556.1; -; Genomic_DNA.
DR   EMBL; AP001059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001060; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09445.1; -; Genomic_DNA.
DR   EMBL; BC002560; AAH02560.1; -; mRNA.
DR   CCDS; CCDS13705.1; -. [Q9UJW3-2]
DR   CCDS; CCDS46650.1; -. [Q9UJW3-1]
DR   RefSeq; NP_037501.2; NM_013369.3. [Q9UJW3-2]
DR   RefSeq; NP_787063.1; NM_175867.2. [Q9UJW3-1]
DR   PDB; 2PV0; X-ray; 3.30 A; A/B/C=1-386.
DR   PDB; 2PVC; X-ray; 3.69 A; A/B/C=1-386.
DR   PDB; 2QRV; X-ray; 2.89 A; B/C/F/G=160-386.
DR   PDB; 4U7P; X-ray; 3.82 A; B=178-379.
DR   PDB; 4U7T; X-ray; 2.90 A; B/D=178-379.
DR   PDB; 5YX2; X-ray; 2.65 A; B/C=178-385.
DR   PDB; 6BRR; X-ray; 2.97 A; B/C=178-386.
DR   PDB; 6F57; X-ray; 3.10 A; B/C=178-386.
DR   PDB; 6KDA; X-ray; 2.91 A; B/C=178-379.
DR   PDB; 6KDB; X-ray; 2.86 A; B/C=178-379.
DR   PDB; 6KDL; X-ray; 3.27 A; B/C=178-379.
DR   PDB; 6KDP; X-ray; 2.93 A; B/C=178-379.
DR   PDB; 6KDT; X-ray; 2.87 A; B/C=178-379.
DR   PDB; 6U8P; X-ray; 3.05 A; B/C=178-386.
DR   PDB; 6U8V; X-ray; 3.00 A; B/C=178-386.
DR   PDB; 6U8W; X-ray; 2.95 A; B/C=178-386.
DR   PDB; 6U8X; X-ray; 2.95 A; B/C=178-386.
DR   PDB; 6U90; X-ray; 3.00 A; B/C=178-386.
DR   PDB; 6U91; X-ray; 3.00 A; B/C=178-386.
DR   PDB; 6W89; X-ray; 2.50 A; B/C/H/I=178-386.
DR   PDB; 6W8B; X-ray; 2.40 A; B/C/I/J=178-386.
DR   PDB; 6W8D; X-ray; 2.60 A; B/C=178-386.
DR   PDB; 6W8J; X-ray; 2.44 A; B/C=178-386.
DR   PDBsum; 2PV0; -.
DR   PDBsum; 2PVC; -.
DR   PDBsum; 2QRV; -.
DR   PDBsum; 4U7P; -.
DR   PDBsum; 4U7T; -.
DR   PDBsum; 5YX2; -.
DR   PDBsum; 6BRR; -.
DR   PDBsum; 6F57; -.
DR   PDBsum; 6KDA; -.
DR   PDBsum; 6KDB; -.
DR   PDBsum; 6KDL; -.
DR   PDBsum; 6KDP; -.
DR   PDBsum; 6KDT; -.
DR   PDBsum; 6U8P; -.
DR   PDBsum; 6U8V; -.
DR   PDBsum; 6U8W; -.
DR   PDBsum; 6U8X; -.
DR   PDBsum; 6U90; -.
DR   PDBsum; 6U91; -.
DR   PDBsum; 6W89; -.
DR   PDBsum; 6W8B; -.
DR   PDBsum; 6W8D; -.
DR   PDBsum; 6W8J; -.
DR   AlphaFoldDB; Q9UJW3; -.
DR   SMR; Q9UJW3; -.
DR   BioGRID; 118984; 82.
DR   ComplexPortal; CPX-6276; DNA (cytosine-5)-methyltransferase 3B complex.
DR   ComplexPortal; CPX-944; DNA (cytosine-5)-methyltransferase 3A complex.
DR   CORUM; Q9UJW3; -.
DR   DIP; DIP-35238N; -.
DR   IntAct; Q9UJW3; 9.
DR   MINT; Q9UJW3; -.
DR   STRING; 9606.ENSP00000270172; -.
DR   BindingDB; Q9UJW3; -.
DR   ChEMBL; CHEMBL3137291; -.
DR   ChEMBL; CHEMBL3885560; -.
DR   REBASE; 4636; M.HsaDnmt3L.
DR   iPTMnet; Q9UJW3; -.
DR   PhosphoSitePlus; Q9UJW3; -.
DR   BioMuta; DNMT3L; -.
DR   DMDM; 334302913; -.
DR   PaxDb; Q9UJW3; -.
DR   PeptideAtlas; Q9UJW3; -.
DR   PRIDE; Q9UJW3; -.
DR   ABCD; Q9UJW3; 1 sequenced antibody.
DR   Antibodypedia; 10145; 594 antibodies from 41 providers.
DR   DNASU; 29947; -.
DR   Ensembl; ENST00000270172.7; ENSP00000270172.3; ENSG00000142182.9. [Q9UJW3-2]
DR   Ensembl; ENST00000628202.3; ENSP00000486001.1; ENSG00000142182.9. [Q9UJW3-1]
DR   GeneID; 29947; -.
DR   KEGG; hsa:29947; -.
DR   MANE-Select; ENST00000628202.3; ENSP00000486001.1; NM_175867.3; NP_787063.1.
DR   UCSC; uc002zeg.3; human. [Q9UJW3-1]
DR   CTD; 29947; -.
DR   DisGeNET; 29947; -.
DR   GeneCards; DNMT3L; -.
DR   HGNC; HGNC:2980; DNMT3L.
DR   HPA; ENSG00000142182; Tissue enhanced (liver).
DR   MIM; 606588; gene.
DR   neXtProt; NX_Q9UJW3; -.
DR   OpenTargets; ENSG00000142182; -.
DR   PharmGKB; PA27447; -.
DR   VEuPathDB; HostDB:ENSG00000142182; -.
DR   eggNOG; ENOG502SIGQ; Eukaryota.
DR   GeneTree; ENSGT00940000162228; -.
DR   InParanoid; Q9UJW3; -.
DR   OMA; EDVCICC; -.
DR   OrthoDB; 1015783at2759; -.
DR   TreeFam; TF329039; -.
DR   PathwayCommons; Q9UJW3; -.
DR   Reactome; R-HSA-5334118; DNA methylation.
DR   SignaLink; Q9UJW3; -.
DR   BioGRID-ORCS; 29947; 6 hits in 1072 CRISPR screens.
DR   EvolutionaryTrace; Q9UJW3; -.
DR   GeneWiki; DNMT3L; -.
DR   GenomeRNAi; 29947; -.
DR   Pharos; Q9UJW3; Tbio.
DR   PRO; PR:Q9UJW3; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; Q9UJW3; protein.
DR   Bgee; ENSG00000142182; Expressed in liver and 57 other tissues.
DR   ExpressionAtlas; Q9UJW3; baseline and differential.
DR   Genevisible; Q9UJW3; HS.
DR   GO; GO:1902494; C:catalytic complex; IPI:ComplexPortal.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; HDA:UniProtKB.
DR   GO; GO:0035098; C:ESC/E(Z) complex; IEA:Ensembl.
DR   GO; GO:0000792; C:heterochromatin; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0090116; P:C-5 methylation of cytosine; IDA:ComplexPortal.
DR   GO; GO:0060718; P:chorionic trophoblast cell differentiation; IEA:Ensembl.
DR   GO; GO:0006306; P:DNA methylation; NAS:UniProtKB.
DR   GO; GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB.
DR   GO; GO:0032776; P:DNA methylation on cytosine; ISS:UniProtKB.
DR   GO; GO:0071514; P:genomic imprinting; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007141; P:male meiosis I; ISS:UniProtKB.
DR   GO; GO:1905642; P:negative regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0010529; P:negative regulation of transposition; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:1905643; P:positive regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0006349; P:regulation of gene expression by genomic imprinting; NAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; ISS:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR025766; ADD.
DR   InterPro; IPR040552; DNMT3_ADD.
DR   InterPro; IPR030486; DNMT3L.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR23068:SF13; PTHR23068:SF13; 1.
DR   Pfam; PF17980; ADD_DNMT3; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51533; ADD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Differentiation; Metal-binding;
KW   Nucleus; Reference proteome; Spermatogenesis; Zinc; Zinc-finger.
FT   CHAIN           1..386
FT                   /note="DNA (cytosine-5)-methyltransferase 3-like"
FT                   /id="PRO_0000088047"
FT   DOMAIN          41..173
FT                   /note="ADD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00865"
FT   ZN_FING         52..82
FT                   /note="GATA-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00865"
FT   ZN_FING         93..149
FT                   /note="PHD-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00865"
FT   VAR_SEQ         332
FT                   /note="S -> SS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10857753"
FT                   /id="VSP_041295"
FT   VARIANT         278
FT                   /note="R -> G (in dbSNP:rs7354779)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_051962"
FT   MUTAGEN         261
FT                   /note="F->A: Loss of binding to DNMT3A."
FT                   /evidence="ECO:0000269|PubMed:17713477"
FT   CONFLICT        246
FT                   /note="P -> A (in Ref. 1; AAF05812)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        266
FT                   /note="L -> F (in Ref. 1; AAF05812)"
FT                   /evidence="ECO:0000305"
FT   HELIX           35..43
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           49..51
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   TURN            54..56
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   STRAND          66..71
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           74..81
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   TURN            82..85
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   STRAND          89..93
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           119..125
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           130..136
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   TURN            143..145
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           160..171
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          192..197
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           200..204
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   TURN            205..207
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          218..222
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           224..226
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           229..234
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          239..244
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          248..250
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           256..269
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          281..286
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           292..301
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          307..310
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:2PV0"
FT   STRAND          320..325
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           329..332
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           340..353
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           361..366
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   HELIX           367..371
FT                   /evidence="ECO:0007829|PDB:6W8B"
FT   TURN            372..374
FT                   /evidence="ECO:0007829|PDB:6W8B"
SQ   SEQUENCE   386 AA;  43583 MW;  65EC2AB7492D53B3 CRC64;
     MAAIPALDPE AEPSMDVILV GSSELSSSVS PGTGRDLIAY EVKANQRNIE DICICCGSLQ
     VHTQHPLFEG GICAPCKDKF LDALFLYDDD GYQSYCSICC SGETLLICGN PDCTRCYCFE
     CVDSLVGPGT SGKVHAMSNW VCYLCLPSSR SGLLQRRRKW RSQLKAFYDR ESENPLEMFE
     TVPVWRRQPV RVLSLFEDIK KELTSLGFLE SGSDPGQLKH VVDVTDTVRK DVEEWGPFDL
     VYGATPPLGH TCDRPPSWYL FQFHRLLQYA RPKPGSPRPF FWMFVDNLVL NKEDLDVASR
     FLEMEPVTIP DVHGGSLQNA VRVWSNIPAI RSRHWALVSE EELSLLAQNK QSSKLAAKWP
     TKLVKNCFLP LREYFKYFST ELTSSL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024